Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
Received: 4 September 2017
Accepted: 18 September 2018
First Online: 3 October 2018
Ethics approval and consent to participate
: The protocol was reviewed and approved by the ethics committees of the study areas (i.e. Landesärztekammer Hessen, Ethik-Kommission der Ärztekammer Nordrhein, and Ethik-Kommission der Medizinischen Fakultät der Universität Münster) and all enrolled patients gave written informed consent.
: Not Applicable.
: RSO, DC and AA are employees of the GSK group of companies. DC and AA own stock options of the GSK group of companies. SM is a freelance consultant working on behalf of GSK Vaccines (Wavre, Belgium). JS has nothing to disclose. US received a grant from the GSK group of companies (as payment for advisory-board meeting) outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.